Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Lidocaine for Tinnitus
NCT02088866Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lidocaine in tinnitus, sponsored by University of California, Davis. Primary endpoint: Tinnitus Functional Index change at 12 weeks. Started Mar 2014; status: completed.
02
Drugs
lidocaine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT02088866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088866.